神経変性疾患治療薬の世界市場:アルツハイマー型認知症、パーキンソン病、多発性硬化症、てんかん、ハンチントン病、筋萎縮性側索硬化症...市場調査レポートについてご紹介

【英文タイトル】Global Neurodegenerative Diseases Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Product Profiles
04.1.1 Avonex/Rebif
04.1.2 Plegridy
04.1.3 Tecfidera
04.1.4 Tysabri
04.1.5 Comtan
04.1.6 Stalevo
04.1.7 Exelon/Exelon Patch
04.1.8 Extavia
04.1.9 Gilenya
04.1.10 Cerebyx
04.1.11 Dilantin-125
04.1.12 Lyrica
04.1.13 Neurontin
04.1.14 Zarontin
04.1.15 Azilect
04.1.16 Copaxone
04.1.17 Keppra/Keppra XR
04.1.18 Neupro
04.1.19 Vimpat

05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology

06.Introduction

07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis

08.Segmentation of Global Neurodegenerative Diseases Market by Type of Disease

09.Global Multiple Sclerosis Market
09.1 Multiple Sclerosis: Overview
09.1.1 About the Disease
09.1.2 Symptoms
09.1.3 Etiology
09.1.4 Epidemiology
09.1.5 Economic Burden
09.2 Market Overview
09.3 Market Size and Forecast
09.4 Multiple Sclerosis Market in US
09.4.1 Market Size and Forecast

10.Global Alzheimer’s Disease Market
10.1 Alzheimer’s Disease: Overview
10.1.1 About the Disease
10.1.2 Dementia
10.1.3 Epidemiology and Forecast
10.1.4 Types of Dementia
10.1.5 Global Burden
10.1.6 Etiology
10.1.7 Cost of Care
10.1.8 Alzheimer’s Disease and Caregiving
10.2 Market Overview
10.3 Market Size and Forecast

11.Global Epilepsy Market
11.1 Epilepsy: Overview
11.1.1 About the Disease
11.1.2 Etiology
11.1.3 Types of Epilepsy
11.1.4 Symptoms
11.1.5 Epidemiology
11.1.6 Economic Burden
11.2 Market Overview
11.3 Market Size and Forecast
11.4 Epilepsy Market in US
11.4.1 Market Size and Forecast
11.5 Epilepsy Market in Europe
11.5.1 Market Size and Forecast
11.6 Epilepsy Market in Japan
11.6.1 Market Size and Forecast

12.Global Parkinson’s Disease Market
12.1 Parkinson’s Disease: Overview
12.1.1 About the Disease
12.1.2 Symptoms
12.1.3 Etiology
12.1.4 Epidemiology
12.1.5 Economic Burden
12.2 Market Overview
12.3 Market Size and Forecast

13.Global Huntington’s Disease Market
13.1 Huntington’s Disease: Overview
13.1.1 About the Disease
13.1.2 Symptoms
13.1.3 Etiology
13.1.4 Prevalence of Huntington’s Disease
13.1.5 Pipeline Portfolio
13.1.6 Economic Burden
13.2 Market Overview
13.3 Market Size and Forecast

14.Global Amyotrophic Lateral Sclerosis Market
14.1 Amyotrophic Lateral Sclerosis: Overview
14.1.1 About the Disease
14.1.2 Types of Amyotrophic Lateral Sclerosis
14.1.3 Etiology and Pathophysiology
14.1.4 Symptoms
14.1.5 Epidemiology
14.1.6 Diagnosis
14.1.7 Pipeline Portfolio
14.2 Market Overview
14.3 Market Size and Forecast

15.Segmentation of Global Neurodegenerative Diseases Market by Type of Molecule
15.1 Biologics
15.2 Small Molecules

16.Segmentation of Global Neurodegenerative Diseases Market by Route of Administration
16.1 Oral
16.2 Parenteral
16.3 Topical

17.Geographical Segmentation

18.Buying Criteria

19.Market Growth Drivers

20.Drivers and their Impact

21.Market Challenges

22.Impact of Drivers and Challenges

23.Market Trends

24.Trends and their Impact

25.Vendor Landscape
25.1 Competitive Scenario
25.1.1 Key News
25.1.2 Mergers and Acquisitions
25.2 Market Share Analysis 2014
25.2.1 Competitive Assessment of Major Drugs
25.2.2 Biogen Idec
25.2.3 Pfizer
25.2.4 Teva Pharmaceutical
25.2.5 Novartis
25.2.6 Merck Serono
25.2.7 UCB
25.3 Other and Potential Future Prominent Vendors

26.Key Vendor Analysis
26.1 Biogen Idec
26.1.1 Key Facts
26.1.2 Business Overview
26.1.3 Business Segmentation by Revenue 2013
26.1.4 Geographical Segmentation by Revenue 2013
26.1.5 Business Strategy
26.1.6 Key Developments
26.1.7 SWOT Analysis
26.2 Merck Serono
26.2.1 Key Facts
26.2.2 Business Overview
26.2.3 Geographical Segmentation by Revenue 2013
26.2.4 Business Strategy
26.2.5 Recent Developments
26.2.6 SWOT Analysis
26.3 Novartis
26.3.1 Key Facts
26.3.2 Business Description
26.3.3 Business Segmentation
26.3.4 Revenue by Business Segmentation
26.3.5 Revenue Comparison 2012 and 2013
26.3.6 Sales by Geography
26.3.7 Business Strategy
26.3.8 Key Developments
26.3.9 SWOT Analysis
26.4 Pfizer
26.4.1 Key Facts
26.4.2 Business Overview
26.4.3 Business Segmentation by Revenue 2013
26.4.4 Business Segmentation by Revenue 2012 and 2013
26.4.5 Geographical Segmentation by Revenue
26.4.6 Business Strategy
26.4.7 Key Developments
26.4.8 SWOT Analysis
26.5 Teva Pharmaceutical
26.5.1 Key Facts
26.5.2 Business Overview
26.5.3 Business Segmentation
26.5.4 Business Segmentation by Revenue 2013
26.5.5 Business Segmentation by Revenue 2012 and 2013
26.5.6 Sales by Geography
26.5.7 Business Strategy
26.5.8 Key Developments
26.5.9 SWOT Analysis
26.6 UCB
26.6.1 Key Facts
26.6.2 Business Overview
26.6.3 Product Segmentation by Revenue 2013
26.6.4 Product Segmentation by Revenue 2012 and 2013
26.6.5 Geographical Segmentation by Revenue 2013
26.6.6 Business Strategy
26.6.7 Recent Developments
26.6.8 SWOT Analysis

27.Other Reports in this Series

List Of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Neurodegenerative Diseases Market 2014-2019 ($ million)
Exhibit 3: Segmentation of Global Neurodegenerative Diseases Market by Type of Disease
Exhibit 4: Segmentation of Global Neurodegenerative Diseases Market by Type of Disease 2014
Exhibit 5: Segmentation of Global Neurodegenerative Diseases Market by Type of Disease 2019
Exhibit 6: Etiology of Multiple Sclerosis
Exhibit 7: Global Multiple Sclerosis Market 2014-2019 ($ million)
Exhibit 8: Multiple Sclerosis Market in US 2014-2019 ($ million)
Exhibit 9: Prevalence of Dementia by Geography 2013, 2030, and 2050 (million)
Exhibit 10: Prevalence of Dementia by Geography 2013-2018 (millions)
Exhibit 11: Types of Dementia and Associated Symptoms
Exhibit 12: Types of Dementia by Prevalence 2013
Exhibit 13: Segmentation of Economic Burden of Alzheimer’s Disease and Other Dementias by Geography 2013
Exhibit 14: Average Cost of Care for Americans Aged 65 and Above with Alzheimer’s Disease and Other Dementias 2013
Exhibit 15: Distribution of Alzheimer’s Caregivers by Age 2013
Exhibit 16: Projected Prevalence of Dependence 2010 and 2030
Exhibit 17: Global Alzheimer’s Disease Market 2014-2019 ($ million)
Exhibit 18: Global Epilepsy Market 2014-2019 ($ million)
Exhibit 19: Epilepsy Market in US 2014-2019 ($ million)
Exhibit 20: Epilepsy Market in Europe 2014-2019 ($ million)
Exhibit 21: Epilepsy Market in Japan 2014-2019 ($ million)
Exhibit 22: Global Parkinson’s Disease Market 2014-2019 ($ million)
Exhibit 23: Segmentation of Global Parkinson’s Disease Market by Country 2014
Exhibit 24: Snapshot of Disease
Exhibit 25: Prevalence of Huntington’s Disease by Geography 2013
Exhibit 26: Huntington’s Disease: Pipeline Portfolio
Exhibit 27: Global Huntington’s Disease Market 2014-2019 ($ million)
Exhibit 28: Snapshot of Disease
Exhibit 29: Amyotrophic Lateral Sclerosis: Pipeline Portfolio
Exhibit 30: Global Amyotrophic Lateral Sclerosis Market 2014-2019 ($ million)
Exhibit 31: Segmentation of Global Neurodegenerative Diseases Market by Type of Molecule
Exhibit 32: Segmentation of Global Neurodegenerative Diseases Market by Type of Molecule 2014
Exhibit 33: Segmentation of Global Neurodegenerative Diseases Market by Route of Administration
Exhibit 34: Segmentation of Global Neurodegenerative Diseases Market by Route of Administration 2014
Exhibit 35: Segmentation of Global Neurodegenerative Diseases Market by Geography 2014
Exhibit 36: Global Neurodegenerative Diseases Market Share Analysis 2014
Exhibit 37: Major Drugs for Neurodegenerative Diseases by Revenue 2014 ($ million)
Exhibit 38: YoY Revenue of Major Drugs for Neurodegenerative Diseases 2011-2014 ($ million)
Exhibit 39: Revenue Share of Major Drugs for Neurodegenerative Diseases 2011-2014
Exhibit 40: Biogen Idec: Global Revenue of Products 2011-2014 ($ million)
Exhibit 41: Biogen Idec: YoY Global Revenue of Avonex 2011-2014 ($ million)
Exhibit 42: Biogen Idec: Revenue of Avonex in US 2011-2014 ($ million)
Exhibit 43: Biogen Idec: Revenue of Avonex in ROW 2011-2014 ($ million)
Exhibit 44: Biogen Idec: YoY Global Revenue of Tysabri 2011-2014 ($ million)
Exhibit 45: Biogen Idec: Revenue of Tysabri in US 2011-2014 ($ million)
Exhibit 46: Biogen Idec: Revenue of Tysabri in ROW 2011-2014 ($ million)
Exhibit 47: Biogen Idec: YoY Global Revenue of Fampyra 2011-2014 ($ million)
Exhibit 48: Biogen Idec: Revenue of Plegridy in US and ROW 2014 ($ million)
Exhibit 49: Biogen Idec: Revenue of Tecfidera in US and ROW 2013 and 2014 ($ million)
Exhibit 50: Pfizer: YoY Global Revenue of Lyrica 2011-2014 ($ million)
Exhibit 51: Pfizer: YoY Global Revenue of Neurontin 2011-2013 ($ million)
Exhibit 52: Teva Pharmaceutical: YoY Global Revenue of Copaxone 2011-2014 ($ million)
Exhibit 53: Teva Pharmaceutical: Quarterly Revenue of Copaxone 2011-2014 ($ million)
Exhibit 54: Teva Pharmaceutical: YoY Global Revenue of Azilect 2011-2014 ($ million)
Exhibit 55: Teva Pharmaceutical: Quarterly Revenue of Azilect 2011-2014 ($ million)
Exhibit 56: Novartis: YoY Global Revenue of Gilenya 2011-2014 ($ million)
Exhibit 57: Novartis: Revenue of Gilenya in US and ROW 2011-2013 ($ million)
Exhibit 58: Novartis: YoY Global Revenue of Extavia 2011-2014 ($ million)
Exhibit 59: Novartis: YoY Global Revenue of Comtan/Stalevo 2011-2014 ($ million)
Exhibit 60: Novartis: Revenue of Comtan/Stalevo in US and ROW 2011-2013 ($ million)
Exhibit 61: Novartis: YoY Global Revenue of Exelon/Exelon Patch 2011-2014 ($ million)
Exhibit 62: Novartis: Revenue of Exelon/Exelon Patch in US and ROW 2011-2013 ($ million)
Exhibit 63: Merck Serono: YoY Global Revenue of Rebif 2011-2014 ($ million)
Exhibit 64: Merck Serono: Revenue of Rebif in North America 2011-2014 ($ million)
Exhibit 65: Merck Serono: Revenue of Rebif in Europe 2011-2014 ($ million)
Exhibit 66: Merck Serono: Revenue Share of Rebif by Region 2012-2014
Exhibit 67: UCB: YoY Global Revenue of Vimpat 2011-2014 ($ million)
Exhibit 68: UCB: YoY Revenue of Vimpat in Europe 2011-2014 ($ million)
Exhibit 69: UCB: YoY Revenue of Vimpat in North America 2011-2014 ($ million)
Exhibit 70: UCB: YoY Global Revenue of Keppra/Keppra XR 2011-2014 ($ million)
Exhibit 71: UCB: YoY Revenue of Keppra/Keppra XR in Europe 2011-2014 ($ million)
Exhibit 72: UCB: YoY Revenue of Keppra/Keppra XR in North America 2011-2014 ($ million)
Exhibit 73: UCB: YoY Global Revenue of Neupro 2011-2014 ($ million)
Exhibit 74: UCB: YoY Revenue of Neupro in Europe 2011-2014 ($ million)
Exhibit 75: UCB: YoY Revenue of Neupro in North America 2011-2014 ($ million)
Exhibit 76: Biogen Idec: Business Segmentation by Revenue 2013
Exhibit 77: Biogen Idec: Geographical Segmentation by Revenue 2013
Exhibit 78: Merck Serono: Geographical Segmentation by Revenue 2013
Exhibit 79: Novartis AG: Business Segmentation
Exhibit 80: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 81: Novartis AG: Revenue by Business Segmentation 2012 and 2013 ($ million)
Exhibit 82: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 83: Pfizer: Business Segmentation by Revenue 2013
Exhibit 84: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 85: Pfizer: Geographical Segmentation by Revenue 2013
Exhibit 86: Teva Pharmaceutical Industries: Business Segmentation
Exhibit 87: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2013
Exhibit 88: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 89: Teva Pharmaceutical Industries: Sales by Geography 2013
Exhibit 90: UCB: Product Segmentation by Revenue 2013
Exhibit 91: UCB: Product Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 92: UCB: Geographical Segmentation by Revenue 2013


【レポート販売概要】

■ タイトル:神経変性疾患治療薬の世界市場:アルツハイマー型認知症、パーキンソン病、多発性硬化症、てんかん、ハンチントン病、筋萎縮性側索硬化症
■ 英文:Global Neurodegenerative Diseases Market 2015-2019
■ 発行日:2015年5月6日
■ 調査会社:Technavio
■ 商品コード:IRTNTR5793
■ 調査対象地域:グローバル
  • 冷凍食品の世界市場2015-2019
    Technavio's research analyst predicts the global frozen food market to grow steadily at a CAGR of 4% during the forecast period. The rise in disposable income and the growing desire for convenience is driving the growth of this market. Consumers prefer ready to eat meals that can reduce their cooking and clean up time. Moreover, the ease of use associated with the packaging technique and the micro …
  • 補助人工心臓の世界市場:左室補助人工心臓(LVAD)、右室補助人工心臓(RVAD)、両心補助人工心臓(BiVAD)
    About Ventricular Assist Devices Heart failure is a medical condition wherein the heart loses its ability to pump enough blood to circulate throughout the body. In such a condition, a patient can survive by having heart transplantation with a healthy heart. A VAD is a medical device that is used to support the patient with either acute or chronic cardiac functional deterioration. It is a mechanica …
  • 世界における小型自動車用ルーフシステム市場動向と予測(~2029)
    This latest just-auto report edition offers a global review of the OE roof systems sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE roof systems market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prosp …
  • パッケージ入りココナッツウォーターの世界市場2018-2022
    About Packaged Coconut Water Coconut water is the liquid endosperm that is extracted from tender coconuts. Categorized as a fruit juice, coconut water is a popular beverage among consumers in tropical countries. Packaged coconut water is prepared by extracting the liquid from coconuts, processing, and then packaging it in cans, bottles; and paper and paperboards. Technavio’s analysts forecast the …
  • ビジネスジェットの世界市場2015-2025
    Visiongain brand new 263 page report assesses that the business jet market will reach $21,065.5m in 2015. A strengthening global economy and a rise in the high net worth individual population mean that demand for business jets is growing. There are several major aircraft manufacturers in this market that offer a diverse portfolio of aircraft types, which fulfil a broad range of capabilities relati …
  • 左心耳(LAA)閉鎖デバイスの世界市場2016-2020
    The left atrial appendage (LAA) is a small ear-shaped sac in the muscle wall of the top left chamber of the heart that controls the electrical impulses during atrial fibrillation. LAA closure device is an interventional device used to prevent stroke, reduce the risk of secondary stroke and emboli because of atrial fibrillation. The global left atrial appendage closure market is expected to grow at …
  • 変圧器の世界市場予測
    Report Description Introduction Transformer is a diverse subject area, which includes both, small and very large systems. Transformer is broadly segmented into distribution transformer, power transformer, and others (instrument transformer). Transformer systems have been dominating the renewable energy market and conventional market in recent years because of the ability to transmit and distribute …
  • 世界の嫌気性消化装置市場2015
    The Global Anaerobic Digestion Equipment Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Anaerobic Digestion Equipment industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Anaerobic Digestion Equipment market analysis is provided for the internationa …
  • リファビッシュ医療機器の世界市場2015-2019
    Refurbished Medical Equipment Refurbishment is a process that ensures the safety and effectiveness of medical equipment without changing the performance of these equipment. Refurbishment is used to maintain the used equipment into its original condition. Unlike remanufacturing, refurbishment does not alter any product specification; it just restore used medical equipment or systems into a conditio …
  • Magellan Midstream Partners, L.P.:石油・ガスバリューチェーン分析レポート2013
    Magellan Midstream Partners, L.P. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Magellan Midstream Partners, L.P." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Magellan Midstream Partners, L.P.”. The report provides key information relating to oil and gas assets of the company along with its operations …
  • 世界のフィトステロール市場2015
    The Global Phytosterols Industry Report 2015 is a professional and in-depth study on the current state of the Phytosterols industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Phytosterols market analysis is provided for the international markets including development trends, competitive landscape analy …
  • 自動車用スチールホイールの世界市場2018-2022
    About Automotive Steel Wheels Automotive steel wheels are circular shaped rims on which the tires are mounted. They are responsible for enabling mobility of an automobile and to carry the weight of the vehicle. From conventional cast-iron wheels to high-performance carbon fiber alloys, automotive wheels have evolved significantly in terms of the materials used to manufacture them. Technavio’s anal …
  • 自動車用アンダーフード電装品の世界市場:制御モジュール、ECU、センサー
    About Automotive Under-the-hood Electronics Under the hood electronics include anti-lock braking systems, ECU control units, electronic fuel injection system, and automated locking systems, among others. In other words, all the mechanical functions of vehicles, which are controlled by electronics or transformed to electronic functionality, are included in engine control components. The automotive …
  • 水性コーティングの世界市場分析:性質別(抗菌、防汚/ぬれ、防汚、防食、セルフクリーニング)、用途別(航空宇宙、自動車、建設、医療、光学)、地域別、動向分析、2014-2025
    The hydrophobic coatings market is projected to reach USD 2.33 billion by 2025, according to a new report by Grand View Research, Inc. The demand for hydrophobic coatings is expected to grow on account of the increasing utilization in various application industries including automotive and construction. The growing emphasis on infrastructure development coupled rising standard of living in develop …
  • ウェスタンブロッティング(WB)の世界市場予測:装置、消耗品
    The western blotting market is expected to reach USD 730.7 Million in 2021 from USD 574.8 Million in 2016, growing at a CAGR of 4.9%. Increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, growing number of industry-academic research collaborations, increasing demand for personalized medicin …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。